GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formosa Pharmaceuticals Inc (TPE:6838) » Definitions » Buyback Yield %

Formosa Pharmaceuticals (TPE:6838) Buyback Yield % : -13.11 (As of Mar. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Formosa Pharmaceuticals Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Formosa Pharmaceuticals's current buyback yield was -13.11%.


Formosa Pharmaceuticals Buyback Yield % Historical Data

The historical data trend for Formosa Pharmaceuticals's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Pharmaceuticals Buyback Yield % Chart

Formosa Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
Get a 7-Day Free Trial - -17.68 -8.46 -14.98 -11.15

Formosa Pharmaceuticals Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.98 - - - -11.15

Competitive Comparison of Formosa Pharmaceuticals's Buyback Yield %

For the Biotechnology subindustry, Formosa Pharmaceuticals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Pharmaceuticals's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formosa Pharmaceuticals's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Formosa Pharmaceuticals's Buyback Yield % falls into.


;
;

Formosa Pharmaceuticals Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Formosa Pharmaceuticals's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 630.449) / 5654.08865
=-11.15%

Formosa Pharmaceuticals's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 630.449) / 5654.08865
=-11.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .


Formosa Pharmaceuticals Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Formosa Pharmaceuticals's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Formosa Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 57, Fuxing North Road, 8th Floor 6, Songshan District, Taipei, TWN, 105
Formosa Pharmaceuticals Inc. is a late-preclinical and early-clinical-stage biopharmaceutical company with a focus on the indications of ophthalmology, oncology, and anti-infectives.

Formosa Pharmaceuticals Headlines

No Headlines